Intranasal cocaine in humans: Effects of sex and menstrual cycle
Introduction
Recently, cocaine has been responsible for more emergency room visits nationwide than any other illegal drug (DAWN. Drug Abuse Warning Network, 2004, CEWG. Community Epidemiology Work Group, 2006), demonstrating that cocaine use is still a widespread public health issue. Although there are a number of studies on the abuse liability of smoked cocaine (e.g. Sofuoglu et al., 2000, Evans et al., 2002, Foltin et al., 2003), many cocaine-dependent individuals initiated cocaine use via the intranasal route (Gorelick, 1992). However, there are few published studies systematically examining intranasal cocaine.
A 2003 nationwide household survey found that 30% of individuals who used cocaine in the past year were women (SAMHSA, 2004) and that more women initiated cocaine use at a younger age than men (NSDUH, 2002). Further, length of time from initiation of cocaine use to onset of abuse and dependence has been shown to be shorter in women compared to men (Ridenour et al., 2005). Thus, women are more vulnerable to cocaine dependence after initiation of cocaine use compared to men. It is not clear whether women have a different subjective response to intranasal cocaine than men, as the effects of intranasal cocaine in females compared to males has yet to be systematically examined.
Intravenous and smoked cocaine's effects differ in cocaine-dependent women compared to men and across the menstrual cycle, but the results have varied as a function of route of administration and experimental paradigm (for review, see Turner and de Wit, 2006). In response to a single administration of intravenous cocaine, no difference was found in the subjective and cardiovascular effects of 0.2 mg/kg or 0.4 mg/kg cocaine between men and women in the follicular or luteal phase of their menstrual cycle (Mendelson et al., 1999). In contrast, repeated administration of a range of intravenous cocaine doses produced a greater response in ratings of “Stimulated” in cocaine-dependent men compared to cocaine-dependent women, and greater cardiovascular effects in cocaine-dependent women compared to cocaine-dependent men (Haney et al., 1998).
Repeated administration of a single dose of smoked cocaine (0.4 mg/kg; Sofuoglu et al., 1999) or a range of smoked cocaine doses (Evans et al., 2002, Evans and Foltin, 2006) produced a similar increase in the positive subjective effects in men and women in their follicular phase. However, the response to cocaine was reduced in women in their luteal phase compared to when they were in their follicular phase or compared to men (Sofuoglu et al., 1999, Evans et al., 2002, Evans and Foltin, 2006). Together, these studies suggest that sex or menstrual cycle phase effects may emerge in response to repeated administration of a range of intravenous or smoked cocaine doses. However, the influence of sex and menstrual cycle on the subjective and cardiovascular effects of a range of intranasal cocaine doses has not been determined.
In response to a single administration of one dose (0.9 mg/kg) of intranasal cocaine, men had higher plasma cocaine levels than women, but there was no difference in subjective and cardiovascular effects between men and women in the follicular or luteal phase of their menstrual cycle (Lukas et al., 1996). However, repeated administration of one dose of intranasal cocaine (2 mg/kg) produced a greater increase in ratings of “Nervous” (Kosten et al., 1996) and four administrations of a single dose of cocaine (1 mg/kg) produced a greater increase in ratings “Feel Good” (McCance-Katz et al., 2005) in women compared to men. These data suggest that women are more sensitive to cocaine's subjective effects, yet no conclusions can be drawn without a full dose–response curve determination.
The primary purpose of the current study was to examine the subjective and cardiovascular effects of two administrations of a range of intranasal cocaine doses in cocaine-dependent women in the luteal phase compared to the follicular phase of the menstrual cycle. A secondary purpose was to compare the same cocaine-dependent women to a group of cocaine-dependent men to determine if sex differences are present. Although the effects of intranasal cocaine in the cocaine-dependent men have been presented elsewhere (Foltin and Haney, 2004), the data will be presented here as well, for comparison purposes, since the same experimental conditions were used as in the current study. We hypothesized that cocaine-dependent women would have a greater response to intranasal cocaine during the follicular phase than the luteal phase of their menstrual cycle. Additionally, we hypothesized that cocaine-dependent women in the follicular phase would have a similar response to intranasal cocaine compared to cocaine-dependent men, but an attenuated response during the luteal phase.
Section snippets
Participants
Eight female research volunteers (five African–American, two Caucasian, one Hispanic), 26 to 44 years of age (mean =33.4 years) and with an average of 14.3 ± 2.3 (mean ± S.D.) years of education, participated in this study. Seven of the participants smoked an average of 13.3 ± 8.3 tobacco cigarettes per day. The participants reported using cocaine by the intranasal route for the past 9.9 ± 8.9 years, using cocaine 3.1 ± 1.9 days per week, and spending US $150 ± 113 per week on cocaine (the cost of cocaine
Menstrual cycle phase effects
Women had normal ovulatory menstrual cycles ranging from 23 to 30 days. In women, estradiol levels were not significantly different in the luteal phase compared to the follicular phase (81.29 ± 17.74 pg/ml vs. 73.64 ± 27.70 pg/ml). Inspection of individual participant estrogen levels revealed that this was due to one participant who had elevated estradiol levels (210 pg/ml) in the follicular phase despite the fact that she was tested on days 8 and 9 of the follicular phase. Progesterone levels in
Discussion
In the current study, there were few differences in subjective or cardiovascular effects or cocaine plasma levels after repeated administration of a range of intranasal cocaine doses in women in their follicular phase compared to when they were in their luteal phase. In contrast, the positive subjective effects of repeated administration of a range of smoked cocaine doses were greater during the follicular phase than the luteal phase in women (Sofuoglu et al., 1999, Evans et al., 2002, Evans
Acknowledgments
This research was supported by Grant No. DA-08105 from the National Institute on Drug Abuse. The participants resided on the Irving Center for Clinical Research at the Columbia-Presbyterian Medical Center, supported by Grant No. MOI-RR-00645 from the National Institutes of Health. The authors gratefully acknowledge the expert assistance of Brenda Faye, R.N., Alyce Stephens, R.N. and Laura Burr R.N. and Drs. Carl Hart, Suzanne Vosburg, Eric Rubin and Eric Collins.
References (30)
Recent discoveries in pharmacokinetics of drugs of abuse
Toxicol Lett
(1998)- et al.
Intranasal cocaine in humans: acute tolerance, cardiovascular and subjective effects
Pharmacol Biochem Behav
(2004) - et al.
Repeated intranasal cocaine administration: lack of tolerance to pressor effects
Drug Alcohol Depend
(1988) - et al.
The effects of escalating doses of smoked cocaine in humans
Drug Alcohol Depend
(2003) - et al.
Gender differences in response to intranasal cocaine administration to humans
Biol Psychiatry
(1996) - et al.
Effect of the menstrual cycle on energy and nutrient intake
Am J Clin Nutr
(1994) - et al.
Cocaine pharmacokinetics in men and in women during the follicular and luteal phases of the menstrual cycle
Neuropsychopharmacology
(1999) - et al.
Factors associated with the transition from abuse to dependence among substance abusers: implications for a measure of addictive liability
Drug Alcohol Depend
(2005) - et al.
Sex differences in the escalation of intravenous cocaine intake following long-or short-access to cocaine self-administration
Pharmacol Biochem Behav
(2004) Epidemiologic trends in drug abuse advance report
(2006)